Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Enzon Pharmaceuticals Inc (NASDAQ:ENZN)

1.38
Delayed Data
As of 2:59pm ET
 +0.01 / +0.73%
Today’s Change
0.78
Today|||52-Week Range
1.88
+39.53%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues7.8M8.2M6.3M5.3M
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses836.0K571.0K468.0K583.0K
 
 
 
 
 
Total Operating Expenses836.0K571.0K468.0K583.0K
 
 
 
 
 
 
Non-Operating ExpensesOperating Income6.9M7.6M5.8M4.7M
 
 
 
 
 
Other Expenses-48.0K0.000.000.00
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income6.9M7.6M5.8M4.7M
 
 
 
 
 
Income Taxes0.00-1.0K0.00-2.5M
 
 
 
Net Income6.9M7.6M5.8M7.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.1M44.1M44.2M44.2M
 
 
 
 
 
Shares To Calculate EPS Diluted44.3M44.2M44.2M44.2M
 
 
 
 
 
 
Earnings Per ShareEPS$0.16$0.17$0.13$0.16
 
 
 
 
 
EPS Diluted$0.16$0.17$0.13$0.16